Professional Documents
Culture Documents
2013 Catalog
NOVA View........................................................................ 6
BIO-FLASH ........................................................................ 8
QUANTA-Lyser ...............................................................10
QUANTA-Lyser 2 ...........................................................11
DS2 ....................................................................................12
Components .....................................................................55
Redefining Autoimmunity
INNOVATIVE ASSAYS
AND INSTRUMENTS
INSTRUMENTS
ASSAYS
analyzer platforms
QUANTA Link workflow
management system
NOVA View digital IFA
DS2 and DSX/best 2000
automated EIA microtiter
NOVA Gel
Ouchterlony
plate platforms
2
Company Overview
INTEGRATING THE
AUTOIMMUNE
LABORATORY
INOVA Diagnostics provides automation
that anticipates the unique requirements of
individual laboratories to improve the efficiency
and quality of autoimmune testing.
QUANTA Link
Centralized Intelligent Network
Description
Part Number
066LINK001
066LINK010
Barcode Scanner
066LINK019
NOVA
View
Digital IFA
Description
Desc
De
scri
ript
ptio
ion
n
Part Number
NV1000
NV1050
NV1051
NV1052
NV1053
NOVA
View
Integrated Autoimmune Laboratory
BIO-FLASH
Rapid-Response Chemiluminescent Analyzer
A progressive solution to
common problems
Eliminates isotype batching and reagent waste
t Stable on-board reagents allow for samples
to be run as they arrive
Improves turn-around time
t Simultaneous random access
processing of all isotypes and assays
on a single sample
t Delivers results, including STAT orders,
in as little as 30 minutes
t BIO-FLASH can generate up to 450
results in a single shift
Helps reduce test send outs
t Makes even the most specialized
assays efficient to perform with stable
calibration curves
Frees up floor space
t Small benchtop analyzer achieves
excellent throughput
Description
Part Number
BIO-FLASH System
T3710-0344
QUANTA-Flash reagents
t Chemiluminescent technology delivers precise quantitation
and a broad analytical measuring range
t Cartridge barcode is internally scanned to import the master calibration
curve, lot number, expiration date and assay type
Reagent carousel
t Stores up to 20 reagent packs with on-board refrigeration
t Monitors reagent use and reports inventory
t Dedicated reagent probe
Sample carousel
t Primary samples placed directly onto the rack and scanned by internal
barcode reader
t Samples processed in random access with continuous load capability
t STAT orders can be run at any time
t Dedicated sample probe
230k
Calibration curves
200k
140k
*
x
x
RLU
170k
110k
90k
60k
30k
*
*
x
0 **
0
60
IU/mL
QUANTA-Lyser
Automated EIA/IFA Analyzer Platform
10
Description
Part Number
GS0162
GS0160
GS0163
GS0242
GS0240
GS0243
QUANTA-Lyser
2
Automated EIA/IFA Analyzer Platform
Part Number
IFA Only
GS2002
EIA + IFA
GS2000
11
DS2
12
Description
Part Number
DS2
D62010
DSX/best 2000
A high-performance walk-away
EIA processing system
t A fully automated 4-plate processing
system capable of performing up to 12
different assays simultaneously
t Employs a modular design that
provides flexible configuration and
ease of use
t Incorporates many features to ensure
the quality and security of results
t Ability to handle a wide variety of
assay protocols
Description
Part Number
With No Incubators
D65100
With 2 Incubators
D65200
With 4 Incubators
T3710-0337
13
QUANTA Flash
Chemiluminescent
Immunoassays (CIA)
QUANTA Flash CIA technology offers a faster response and
broader analytical measuring range than enzyme-based
assays for more precise quantitation
ANALYTICAL MEASURING RANGE
and confidence in results.
Antiphospholipid Syndrome
Connective Tissue Diseases
Celiac Disease
Vasculitis
Rheumatoid Arthritis
ELISA
QUANTA Flash
Measured units
14
1. Martis P, et al. The QUANTA Flash Chemiluminescent Immunoassays for Celiac Disease
Show Excellent Analytical and Clinical Performance Characteristics. AMLI Minneapolis, 2011.
Celiac Disease
QUANTA Flash celiac assays provide accurate results across multiple markers and isotypes.
NAME
DESCRIPTION
PRODUCT ITEM
PACKAGE
PART #
QUANTA Flash
h-tTG IgA
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701103
701101
701102
QUANTA Flash
h-tTG IgG
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701108
701106
701107
QUANTA Flash
DGP IgA
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701168
701166
701167
QUANTA Flash
DGP IgG
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701173
701171
701172
QUANTA Flash
DGP Screen
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701113
701111
701112
Vasculitis
QUANTA Flash MPO, PR3 and GBM allow for rapid response in critical cases.
NAME
DESCRIPTION
PRODUCT ITEM
PACKAGE
PART #
QUANTA Flash
MPO
Reagents
Calibrator
Controls
50 Test Cartridge
2 X 2 vials (0.7 mL each)
2 X 2 vials (0.5 mL each)
701133
701131
701132
QUANTA Flash
PR3
Reagents
Calibrator
Controls
50 Test Cartridge
2 X 2 vials (0.3 mL each)
2 X 2 vials (0.5 mL each)
701138
701136
701137
QUANTA Flash
GBM
Reagents
Calibrator
Controls
50 Test Cartridge
2 X 2 vials (0.7 mL each)
2 X 2 vials (0.5 mL each)
701143
701141
701142
15
NAME
DESCRIPTION
PRODUCT ITEM
PACKAGE
PART #
QUANTA Flash
Cardiolipin IgG
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701233
701232
QUANTA Flash
Cardiolipin IgM
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701238
701237
QUANTA Flash
Cardiolipin IgA*
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701228
701227
QUANTA Flash
2 GPI IgG
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701248
701247
QUANTA Flash
2 GPI IgM
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701253
701252
QUANTA Flash
2 GPI IgA*
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701243
701242
QUANTA Flash
2 GPI Domain1*
Reagents
Controls
50 Test Cartridge
2 X 3 vials (1 mL each)
701188
701187
DESCRIPTION
PACKAGE
PART #
1 X 5L
T3000-8205
2 x 250mL
T3000-8204
T3000-8206
6 x 4mL
T3000-8211
Trigger 1&2
Cuvettes
Low volume sample cups for use with the BIO-FLASH system.
500 Cups
T3000-8209
Low volume sample cup caps for use with the BIO-FLASH system.
500 Caps
T3000-8210
16
DESCRIPTION
PRODUCT ITEM
PACKAGE
PART #
QUANTA Flash
ENA 7 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701258
701256
701257
QUANTA Flash
Jo-1 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701163
701161
701162
QUANTA Flash
RNP *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701118
701116
701117
QUANTA Flash
Sm *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701123
701121
701122
QUANTA Flash
Ro60 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701148
701146
701147
QUANTA Flash
Ro52 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701263
701261
701262
QUANTA Flash
SS-B *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701153
701151
701152
QUANTA Flash
Scl-70 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701158
701156
701157
QUANTA Flash
Centromere *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701198
701196
701197
QUANTA Flash
RiboP *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701193
701191
701192
QUANTA Flash
DFS70 *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.3mL each)
2 X 2 vials (0.5mL each)
701268
701266
701267
QUANTA Flash
dsDNA *
Reagents
Calibrators
Controls
50 Test Cartridge
2 X 2 vials (0.5mL each)
2 X 2 vials (0.5mL each)
701178
701176
701177
17
QUANTA Lite
ELISA
QUANTA Lite ELISA tests are made of the
highest quality components to enable semiquantitative detection of autoantibodies for
a variety of disease states:
Antiphospholipid
Gastrointestinal Disease
Syndrome
Connective Tissue
Diseases
Rheumatoid
Arthritis
18
Celiac Disease
Liver Disease
Vasculitis
Autoimmune Thyroid
Disease
QUANTA Lite ELISA tests are semi-quantitative unless otherwise indicated in the product description
Gastrointestinal Disease
The cause of chronic intestinal upset can come from a number of sources, often making diagnosis difficult. The QUANTA Lite and
NOVA Lite (in the case of ANCA) tests below provide reliable results to help clinicians assess the root cause.
()
Suggestive of
Celiac Disease
(+)
(+)
(+)
ASCA
pANCA
H. pylori
GPA/intrinsic
factor
Suggestive of
Crohns Disease
Suggestive of
Ulcerative Colitis
Suggestive of
Gastritis
()
Suggestive of
Atrophic Gastritis/
Pernicious Anemia
()
Suggestive of
Irritable Bowel
Syndrome
Abbreviations
ANCA
Anti-neutrophil cytoplasmic antibodies
ASCA
Anti-Saccharomyces cerevisiae antibody
DGP
Anti-deamidated gliadin peptide
EMA
Anti-endomysial antibody
GPA
Anti-gastric parietal antibody
H. pylori
Anti-Helicobacter pylori antibody
tTG
Anti-tissue transglutaminase antibody
Suggestive of
Non-Celiac Gluten
Sensitivity
Test
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
1. Green, P. H. (2009). "Mortality in celiac disease, intestinal inflammation, and gluten sensitivity." JAMA 302(11): 1225-1226.
2. Rubio-Tapia, A. and Murray, J. A. (2010). "Celiac disease." Curr Opin Gastroenterol 26(2): 116-122.
3. Leffler, D. A. and D. Schuppan (2010). "Update on serologic testing in celiac disease." Am J Gastroenterol 105(12): 2520-2524.
19
IBD
Differential Diagnosis
of Crohns Disease or
Ulcerative Colitis
RESULTS:
ASCA IgG ASCA IgA pANCA +
(atypical)
PR3+
RESULTS:
ASCA IgG +
ASCA IgA +
pANCA (atypical)
INFLAMMATORY BOWEL
DISEASE DIAGNOSIS
ASCA LEVEL
OVERLAP CONDITIONS
ANCA LEVEL
Suggestive of
Suggestive of
CROHNS DISEASE
ULCERATIVE COLITIS
Abbreviations
ASCA
Anti-Saccharomyces cerevisiae antibody
pANCA
Perinuclear anti-neutrophil cytoplasmic antibody
PR3
Proteinase 3
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
1. Desplat-Jego, S., Johanet, C., et al. (2007). "Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and
antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter
study." World J Gastroenterol 13(16): 2312-2318.
2. Arai, R. (2010). "Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease." Postgrad Med 122(4): 177-185.
3. Arias-Loste, et al. (2012). "Presence of Anti-proteinase 3 Antineutrophil Cytoplasmic Antibodies (Anti-PR3 ANCA) as Serologic Markers in Inflammatory Bowel
Disease" Clinical Reviews in Allergy & Immunology, in press
20
Gastrointestinal Disease
NAME
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
708720
Native
1 X 96 wells
708715
This assay is designed for the detection of antiSaccharomyces cerevisiae IgA antibodies in human serum.
The presence of these antibodies can aid in the diagnosis of
patients with Crohn's disease.
Native
1 X 96 wells
708870
This assay is designed for the detection of antiSaccharomyces cerevisiae IgG antibodies in human serum.
The presence of these antibodies can aid in the diagnosis of
patients with Crohn's disease.
Native
1 X 96 wells
708865
Native
1 X 96 wells
708765
Recombinant
1 X 96 wells
708780
QUANTA Lite
Intrinsic Factor
DESCRIPTION
21
NAME
ANTIGEN
PACKAGE
PART #
Native
(human red
blood cell)
1 X 96 wells
10 X 96 wells
708760
708760.10
Native
(human red
blood cell)
1 X 96 wells
708755
Recombinant
1 X 96 wells
10 X 96 wells
704605
704605.10
Recombinant
1 X 96 wells
10 X 96 wells
704610
704610.10
QUANTA Lite
h-tTG Screen
Native
(human red
blood cell)
1 X 96 wells
704570
QUANTA Lite
Gliadin IgA II (DGP)
Synthetic,
deamidated
peptide
1 X 96 wells
10 X 96 wells
704525
704525.10
QUANTA Lite
Gliadin IgG II (DGP)
Synthetic,
deamidated
peptide
1 X 96 wells
10 X 96 wells
704520
704520.10
QUANTA Lite
Celiac DGP Screen
Synthetic,
deamidated
peptide
1 X 96 wells
704545
22
DESCRIPTION
DESCRIPTION
ANTIGEN
PACKAGE
PART #
h-tTG native
(human red
blood cell);
DGP peptide
(synthetic,
deamidated)
1 X 96 wells
704575
QUANTA Lite
h-tTG/DGP Screen
Native
1 X 96 wells
708655
Native
1 X 96 wells
708650
Native
1 X 96 wells
704500
23
DIAGNOSTIC ALGORITHM
Liver Disease of Unknown Cause
ANA+
SMA+
LKM+
AIH
F-actin+
(lgG)
PBC
SLA/LP+
AIH
LC1+
Additional assays to
establish &/or clarify
diagnosis**
Atypical
ANCA+
AMA+
AIH
PSC
AMA specific
antigens
M2EP (MIT3)*+
gp210+
&/or
sp100+
PBC
Abbreviations
AIH
autoimmune hepatitis
AMA
anti-mitochondrial antibodies
ANA
anti-nuclear antibodies
ANCA
anti-neutrophil cytoplasmic antibodies
DGP
deamidated gliadin peptide
EMA
endomysium antibody
LKM
liver-kidney microsomal antibody
PBC
primary biliary cirrhosis
PSC
primary sclerotic cholangitis
SLA
soluble liver antigen
SMA
smooth muscle antibody
tTG
tissue transglutaminase
EMA+
tTG+
DGP+
Celiac
Test
Negative
Cryptogenic
chronic
hepatitis
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
From: A.J. Czaja & G.L. Norman, J. Clin. Gastrenterol, 2003, 37:315-327, modified by G.L. Norman 01/09
** Other assays with possible prognostic value: chromatin and dsDNA
* M2 EP (MIT3) ELISA contains immunodominant epitope of PDC-E2, OGDC-E2 & BCOADC-E2
24
AIC
Liver Disease
NAME
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
10 X 96 wells
708785
708785.10
QUANTA Lite
M2 EP (MIT3)
1 X 96 wells
10 X 96 wells
704540
704540.10
Synthetic
peptide
1 X 96 wells
708995
Synthetic
peptide
1 X 96 wells
708990
QUANTA Lite
PBC Screen IgG/IgA
MIT3
This assay is designed for the detection of antirecombinant;
mitochondrial, -gp210 and -sp100 IgG and/or IgA antibodies
sp100 &
in human serum. The presence of these antibodies can aid in
gp210
the diagnosis of primary biliary cirrhosis.
synthetic
peptides
1 X 96 wells
704560
Recombinant
1 X 96 wells
708775
Recombinant
1 X 96 wells
708745
25
All negative
If clinical suspicion
is high, test aCL/
aB2GP1 IgA and
aPS/PT IgG and IgM
LAC positive
(regardless of other
antibodies)
If clinical criteria
fulfilled, APS is very
likely; Treat patient,
repeat testing in
12 weeks
If clinical criteria
fulfilled, APS is very
likely; Treat patient,
repeat testing in
12 weeks
If clinical criteria
fulfilled, APS is
possible; Treat
patient, repeat
testing in 12 weeks;
Consider testing for
aCL/aB2GP1 IgA and
aPS/PT IgG and IgM
Consider aPS/PT
testing
Test
Abbreviations
aCL
anti-cardiolipin
APS
anti-phospholipid syndrome
-2 GP1
beta-2 glycoprotein I
LAC
lupus anticoagulant
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
* IgA aCL and 2GP1 antibodies are not part of the current APS classification criteria.
** Lupus anticoagulant test is not provided by INOVA
1. Bertolaccini, M. L., Amengual, O., Atsumi, T., Binder, W. L., de Laat, B., Forastiero, R., Kutteh, W. H., et al. (2011). Non-criteria aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus, 20(2), 191-205. doi:10.1177/0961203310397082
2. Galli M. Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost. 2012 Jun;38(4):348-52.
3. Otomo K, Atsumi T, Amengual O, Fujieda Y, Kato M, Oku K, Horita T, Yasuda S, Koike T. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. Arthritis Rheum. 2012 Feb;64(2):504-12.
26
Antiphospholipid Syndrome
NAME
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
10 X 96 wells
708625
708625.10
Native
1 X 96 wells
10 X 96 wells
708630
708630.10
Native
1 X 96 wells
10 X 96 wells
708635
708635.10
Native
1 X 96 wells
708620
Native
1 X 96 wells
10 X 96 wells
708665
708665.10
Native
1 X 96 wells
10 X 96 wells
708670
708670.10
Native
1 X 96 wells
10 X 96 wells
708675
708675.10
Native
1 X 96 wells
708660
27
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
708835
Native
1 X 96 wells
708845
QUANTA Lite
Phosphatidylserine IgG
Native
1 X 96 wells
10 X 96 wells
704625
704625.10
QUANTA Lite
Phosphatidylserine IgM
Native
1 X 96 wells
10 X 96 wells
704630
704630.10
QUANTA Lite
Phosphatidylserine IgA
Native
1 X 96 wells
10 X 96 wells
704635
704635.10
28
Rheumatoid Arthritis
The revised classification criteria issued in 2010 for rheumatoid arthritis (RA) emphasize the need for early and accurate diagnosis. The
QUANTA Lite CCP3.1 IgG/IgA ELISA offers superior detection of early RA compared with CCP21. Clearly defined positive and high positive
cut-offs provide results that rheumatologists require.
NAME
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Synthetic
peptide
1 X 96 wells
10 X 96 wells
704550
704550.10
Synthetic
peptide
1 X 96 wells
10 X 96 wells
704535
704535.10
Native
1 X 96 wells
708685
Native
1 X 96 wells
708690
Native
1 X 96 wells
708695
29
NAME
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native,
recombinant,
extracts from
HEp-2 nuclei
and nucleoli
1 X 96 wells
708750
Native
1 X 96 wells
708510
Native
1 X 96 wells
704650
Native
1 X 96 wells
704615
QUANTA Lite
Chromatin
Native
1 X 96 wells
708710
Native
1 X 96 wells
704620
Native
1 X 96 wells
704565
Recombinant
1 X 96 wells
708770
QUANTA Lite
Centromere (CENP-A &
CENP-B)
30
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
708520
Native
1 X 96 wells
708585
QUANTA Lite
Ribosome P
Synthetic
peptide
1 X 96 wells
708600
1 X 96 wells
704555
Native
1 X 96 wells
708565
Native
1 X 96 wells
708580
QUANTA Lite Sm
Native
1 X 96 wells
708560
SS-A 52
recombinant;
SS-A 60
native
1 X 96 wells
708570
Recombinant
1 X 96 wells
704505
31
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
708575
Native
1 X 96 wells
708525
SS-A 52
This assay is designed for the detection of anti-Sm, RNP, SS-A
recombinant;
(60kDa and 52kDA) and SS-B IgG antibodies in human serum. The
SS-A 60
presence of these antibodies can aid in the diagnosis of systemic
native; SS-B
lupus erythematosus (SLE) and related connective tissue diseases, native; Sm
such as Sjgren's Syndrome.
native; RNP
native
1 X 96 wells
708555
SS-A 52
recombinant;
SS-A 60
native; SS-B
native; Sm
native; RNP
native; Scl-70
native
1 X 96 wells
708610
SS-A 52
recombinant;
SS-A 60
This assay is designed for the detection of anti-Sm, RNP, SS-A
(60kDa and 52kDa), SS-B, Scl-70 and Jo-1 IgG antibodies in human native; SS-B
native; Sm
serum. The presence of these antibodies can aid in the diagnosis
native; RNP
of systemic lupus erythematosus (SLE), and related connective
native; Scl-70
tissue diseases, such as Sjgren's Syndrome.
native; Jo-1
native
1 X 96 wells
708615
1 X 96 wells
704715
32
Combined
Vasculitis
Newly acquired technology has allowed for an important expansion in INOVAs vasculitis menu with the addition of the QUANTA
Lite PR3 SC and QUANTA Lite MPO SC, both offering 5 point standard curve calibration.
NAME
DESCRIPTION
ANTIGEN
PACKAGE
PART #
This assay is designed for the detection of antimyeloperoxidase (MPO) IgG antibodies in human serum.
The presence of these antibodies can aid in assessing certain
autoimmune vasculitides such as microscopic polyarteritis,
and crescentic glomerulonephritis.
Native
1 X 96 wells
10 X 96 wells
708700
708700.10
Native
1 X 96 wells
10 X 96 wells
704655
704655.10
Native
1 X 96 wells
10 X 96 wells
708705
708705.10
Native
1 X 96 wells
10 X 96 wells
704660
704660.10
Native
1 X 96 wells
10 X 96 wells
708740
708740.10
DESCRIPTION
ANTIGEN
PACKAGE
PART #
Native
1 X 96 wells
708595
Recombinant
1 X 96 wells
708725
33
DESCRIPTION
PACKAGE
PART #
QUANTA Chek
ANA Panel
The QUANTA Chek ANA Panel is used for quality control of IFA and ELISA
antinuclear antibody procedures. Each serum serves as both a pattern
control and a titratable sensitivity control. The staining pattern and intensity
for each serum has been calibrated by testing it on NOVA Lite HEp-2 slides
and QUANTA Lite ANA kits.
10 X 0.15mL
708111
QUANTA Chek
ANCA Panel
The QUANTA Chek ANCA Panel is used for quality control of IFA and ELISA
autoantibody procedures. Each serum serves as both a pattern control and
a titratable sensitivity control. The staining pattern and intensity for each
serum has been calibrated by testing it on INOVA Diagnostics' Neutrophil
slides and QUANTA Lite MPO and PR-3 kits.
8 X 0.15mL
708112
QUANTA Chek
Celiac Panel
The QUANTA Chek Celiac Panel is used for quality control of IFA and ELISA
autoantibody procedures. Each serum serves as both a pattern control and
a titratable sensitivity control. The staining pattern and intensity for each
serum has been calibrated by testing it on NOVA Lite Endomysial slides and
QUANTA Lite h-tTG IgA, h-tTG IgG, Gliadin IgG II and Gliadin IgA II kits.
8 X 0.15mL
708113
QUANTA Chek
Coagulation Panel
The QUANTA Chek Coagulation Panel is used for quality control of ACA
and 2GPI autoantibody ELISA procedures. Each serum serves as both a
sensitivity and specificity control. Each serum has been calibrated by testing
it on QUANTA Lite ACA and QUANTA Lite 2GPI kits.
8 X 0.15mL
708114
QUANTA Chek
ENA Panel
The QUANTA Chek ENA Panel is used for quality control of extractable
nuclear antibody (ENA) assay in the QUANTA Lite ENA ELISA procedure. Each
serum serves as both a sensitivity and a specificity control. Each serum has
been calibrated by testing it on QUANTA Lite ENA ELISA kits.
8 X 0.15mL
708115
34
DESCRIPTION
PACKAGE
PART #
1 X 0.1mL
508668
1 X 0.1mL
508673
5 X 1.2mL
508512
6 X 1.2mL
504528
6 X 1.2mL
504524
5 X 1.2mL
508763
6 X 1.2mL
508744
6 X 1.2mL
508703
6 X 1.2mL
508708
35
NOVA Lite
36
ANCA IFA
pANCA / cANCA
negative
atypical ANCA
positive
pANCA or cANCA
positive
Clinical suspicion of
autoimmune small vessel
vasculitis low
Clinical suspicion of
autoimmune small vessel
vasculitis low; consider
testing for ASCA
Abbreviations
MPO
myeloperoxidase
PR-3
proteinase 3
ANCA
anti-neutrophil cytoplasmic antibodies
ASCA
anti-Saccharomyces cerevisiae antibody
MPO positive
PR3 positive
Consider
microscopic
polyangiitis
(60% positive) or
granulomatosis
with polyangiitis
(Wegener's)
(25% positive)
Consider
microscopic
polyangiitis
(30% positive) or
granulomatosis
with polyangiitis
(Wegener's)
(60% positive)
Test
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
Savige, J. et al, Am J Clin Path 112 (1), 1999
37
HEp-2
DIAGNOSTIC ALGORITHM
HEp-2
POSITlVE
Nuclear
staining
Coarse
speckled
Fine
speckled
Homogeneous
Nuclear
Dots
Nucleolar
Centromere
PCNA
Consider Progressive
Systemic Sclerosis or
Polymyositis/
Scleroderma overlap
(mixed pattern with
positive chromosomes
may indicate ScI-70)
CREST variant
of Progressive
Systemic
Sclerosis
Marker
antibody for
SLE
Confirmatory
Testing
dsDNA and/or
chromatin
Histone
Sm
RNP
SS-A 52
SS-A 60
SS-B
Scl-70
Active
SLE
Drug induced
SLE
SLE marker
antibody
MCTD or
milder SLE
SLE,
Sjgren's
Syndrome,
Systemic
Sclerosis,
PM/DM
SLE,
Sjgren's
Syndrome,
Systemic
Sclerosis
SLE,
Sjgren's
Syndrome,
Neonatal
SLE
Scleroderma
marker
antibody
associated
with
Scleroderma
Scleroderma,
especially
diffuse
cutaneous form;
also associated
with risk of
renal crisis
Abbreviations
CREST
calcinosis, raynaud's phenomenon, esophageal dysmotility,
sclerodactyly, telangiectasia
ds-DNA
double stranded DNA
ENA
extractable nuclear antibody
MCTD
mixed connective tissue disease
PBC
primary biliary cirrhosis
PCNA
Proliferating Cell Nuclear Antigen
PM/DM
RNP
Scl-70
SS-A
SS-B
Sm
SLE
polymyositis/dematomyositis
ribonucleoprotein
scleroderma antigen (70kD)
Sjgrens syndrome A antigen
Sjgrens syndrome B antigen
Smith antigen
systemic lupus erythematosus
Testing strategies provided for informational purposes only. Testing and diagnosis should be determined by a licensed clinician.
38
NEGATIVE
Cytoplasmic
staining
Nuclear
membrane
(rim)
sp100
Mitochondrial
gp 210
Retest on
rodent tissue
Primary Biliary
Cirrhosis (PBC)
M2 EP
(MIT-3)
Mitotic
Jo-1
Spindle
Ribosomal P
Jo-1
Various
rheumatic
diseases
Low % of SLE
patients but
highly specific
PM/DM
Ribosomal
Golgi
Immunofluorescent (IF)
major patterns
Reflex test
Centromere
Associated disease state
CREST
39
ANCA PATTERNS
SUBSTRATE PATTERN CHART
SUBSTRATE
ETHANOL
FIXED SLIDE
FORMALIN FIXED
SLIDE
HEp-2
SLIDE
Granular Cytoplasmic
Granular Cytoplasmic
Negative
Perinuclear
Granular Cytoplasmic
Negative
Very Perinuclear
Negative
Negative
Perinuclear or Homogeneous
Positive
Negative
Negative
Negative
CANCA*
PANCA*
ATYPICAL P-ANCA*
ANA POSITIVE
NEGATIVE
* Consider confirmatory testing with QUANTA Lite or QUANTA Flash MPO and PR-3.
40
F-Actin on IEC-6
NOVA Lite IgG F-Actin
41
HOMOGENEOUS
SPECKLED
SS-A
Scl-70
DFS-70
LAMIN
42
gp210
CENTRIOLE
RIBOSOMAL
RNA POL I
Jo-1
FLUORESCENCE PATTERNS
CENTROMERE
NUCLEOLAR
PCNA
PM-Scl
AMA + sp100
NuMA
CENP-F
PERICENTROSOMES
GW BODIES
GOLGI
43
PACKAGE
PART #
10 X 6 wells
(new formulation)
(classic formulation)
708299
708290
20 X 12 wells
(new formulation)
(classic formulation)
708298
708296
(DAPI conjugate)*
708301
10 X 6 wells
20 X 12 wells
(DAPI conjugate)*
708295
708297
708300
An indirect immunofluorescent assay for the screening and semiquantitative determination of anti-nuclear IgG antibodies (ANA) in
human serum. The presence of these antibodies can aid in the diagnosis
of systemic lupus erythematosus (SLE), or other connective tissue or
rheumatic diseases. Fluorescein labeled anti-human IgG conjugate with
Evan's Blue - ready to use.
5 X 12 wells
20 X 12 wells
(DAPI conjugate)*
708101
708100
708102
10 X 6 wells
20 X 12 wells
704230
704235
An indirect immunofluorescent assay for the screening and semiquantitative determination of anti-double stranded DNA (dsDNA) IgG
antibodies in human serum. The presence of these antibodies can aid in
the diagnosis of systemic lupus erythematosus (SLE). Fluorescein labeled
anti-human IgG conjugate no Evan's Blue - ready to use.
10 X 6 wells
20 X 12 wells
708200
708205
An indirect immunofluorescent assay for the screening and semiquantitative determination of IgG anti-nuclear antibodies (ANA), antimitochondrial (AMA), anti-smooth muscle (ASMA) and gastric parietal
antibodies (GPA) in human serum. The presence of these antibodies can aid
in the diagnosis of systemic lupus erythematosus (SLE), or other connective
tissue or rheumatic diseases. Fluorescein labeled anti-human IgG conjugate
with Evan's Blue - ready to use.
10 X 4 wells
25 X 8 wells
708390
708380
This product is intended for use in the screening and titration of circulating
autoantibodies in human serum as an aid in the diagnosis and treatment
of various autoimmune diseases. The four major autoantibodies detected
10 X 5 wells 25 X 10
are antinuclear antibodies (ANA), antimitochondrial antibodies (AMA),
wells
antismooth muscle antibodies (ASMA) and antigastric parietal cell antibodies
(AGPCA). Fluorescein labeled anti-human IgG (H&L) conjugate - ready to use.
DESCRIPTION
An indirect immunofluorescent assay for the screening and semiquantitative determination of anti-neutrophil cytoplasmic IgG antibodies
(ANCA) in human serum. The presence of these antibodies can aid in the
assessment of various systemic vasculitides. Fluorescein labeled antihuman IgG conjugate with Evan's Blue - ready to use.
44
704170
704180
DESCRIPTION
PACKAGE
PART #
10 X 4 wells
20 X 8 wells
708155
708150
5 x 6 wells
708255
Monkey esophagus sections are intended for use as a substrate for the screening
of antibodies to intra-epidermal antigens or basement membrane zones in
human serum, as an aid in the diagnosis of pemphigus and bullous pemphigoid 10 X 5 wells
respectively. The sections can also be used for detection of endomysial
25 X 10 wells
antibodies as an aid in the diagnosis of celiac disease. Fluorescein labeled antihuman IgG (H&L) conjugate and anti-human IgA conjugate - ready to use.
704145
704150
Monkey esophagus sections are intended for use as a substrate for the detection
25 X 10 wells
of endomysial antibodies as an aid in the diagnosis of celiac disease. Includes
(multi channel)
IgA conjugate only. Fluorescein labeled anti-human IgA conjugate - ready to use.
704155
704255
Monkey esphagus sections are intended for use as a substrate for the screening
of autoantibodies to intra-epidermal antigens or basement membrane zones
in human serum, as an aid in the diagnosis of bullous pemphigus and bullous
pemphigoid respectively. The sections may not contain endomysial tissue
and therefore, should not be used for detection of endomysial antibodies.
Fluorescein labeled anti-human IgG (H&L) conjugate - ready to use.
10 X 5 wells
25 X 10 wells
704160
704165
10 X 8 wells
708330
10 X 5 wells
704240
10 X 8 wells
708350
45
PACKAGE
PART #
1 X 6 wells
1 X 12 wells
10 X 6 wells
20 X12 wells
508299
508298
508299.10
508298.20
1 X 6 wells
10 X 6 wells 1
X 12 wells
20 X 12 wells
508295
508295.10
508297
508297.20
1 X 6 wells
508280
508105
508100
508100.10
508100.20
508100.80
508105.10
DESCRIPTION
1 X 6 wells
1 X 12 wells
10 x 12 wells
20 x 12 wells
80 x 12 wells
10 X 6 wells
HEp-2 (human epithelial cell) substrate slide fixed to detect actin fibers
1 X 6 wells
1 X 12 wells
508095
508090
1 X 6 wells
1 X 12 wells
10 X 6 wells
20 X 12 wells
80 X 12 wells
508200
508205
508200.10
508205.20
508205.80
1 X 8 wells
508170
1 X 4 wells
1 X 8 wells
10 X 4 wells
30 X 8 wells
508155
508150
508155.10
508150.30
1 X 4 well
1 X 8 wells
10 X 4 wells
30 X 8 wells
508385
508380
508385.10
508380.30
1 X 5 wells
1 X 10 wells
10 X 5 wells
25 X 10 wells
504170
504180
504170.10
504180.25
1 X 4 wells
1 X 8 wells
508392
508393
46
DESCRIPTION
PACKAGE
PART #
504145
504150
504145.10
504150.25
1 X 5 wells
1 X 10 wells
10 X 5 wells
25 X 10 wells
Monkey Esophagus (skin antibodies only) IFA Slide (the sections may not
contain endomysial tissue)
1 X 5 wells
1 X 10 wells
10 X 5 wells
504160
504165
504160.10
1 X 4 wells
1 X 8 wells
508335
508330
1 X 5 wells
10 X 5 wells
504215
504215.10
1 X 4 wells
1 X 8 wells
508336
508337
1 X 4 wells
1 X 8 wells
508355
508350
1 X 4 wells
1 X 8 wells
10 X 4 wells
508375
508370
508375.10
1 X 5 wells
10 X 5 wells
504225
504225.10
1 X 4 wells
10 X 4 wells
508357
508357.10
1 X 4 wells
508362
1 X 4 wells
508358
1 X 4 wells
508345
1 X 4 wells
10 X 4 wells
508356
508356.10
1 X 4 wells
1 X 8 wells 10
X 4 wells
508315
508310
508315.10
47
DESCRIPTION
PACKAGE
PART #
1 X 4 wells
508364
1 X 4 wells
508373
1 X 5 wells
10 X 5 wells
504220
504220.10
1 X 4 wells
10 X 4 wells
508366
508366.10
1 X 4 wells
10 X 4 wells
508367
508367.10
1 X 4 wells
508368
1 X 4 wells
10 X 4 wells
508320
508320.10
1 X 4 wells
508369
1 X 4 wells
508372
1 X 4 wells
508360
1 X 5 wells
10 X 5 wells
504210
504210.10
1 X 5 wells
10 X 5 wells
504240
504240.10
1 X 6 wells
508255
48
Common Components
NAME
DESCRIPTION
PACKAGE
PART #
1 X 1.0mL
508007
1 X 1.0mL
508186
1 X 2.5mL
508115
1 X 2.5mL
504049
1 X 25.0mL
508003
1 X 25.0mL
508002
1 X 25.0mL
508998
Mounting Medium
1 X 3.0mL
1 X 7.0mL
1 X 10.0mL
508006
508001
508005
Mounting Medium-PVA
1 X 3.0mL
1 X10.0mL
504046
504047
Urea Buffer*
Urea Buffer (as used with the NOVA Lite Monkey Kidney Kit 704240)
1 X 13.0mL
504084
Anti AB Neutralising
Reagent *
1 X 5.0mL
504056
Coverslips
10 coverslips
20 coverslips
10 each
20 each
508122
508112
PACKAGE
PART #
Demonstration Slides
NAME
DESCRIPTION
HEp-2 Demonstration
Slide
1 X 12 wells
518100
HEp-2 Demonstration
Slide Actin
1 X 12 wells
518090
2 X 6 wells
518290
*ANCA
Available
Outside The USA Only
Demonstration
ANCA Demonstration Slide. 1 Ethanol and 1 Formalin, 2x6 wells
Slide
Distal Esophagus
Demonstration Slide
1 X 4 wells
518336
1 X 8 wells
518150
49
NOVA Lite antibody controls are designed for use with the NOVA Lite slides. Convenient volumes and ready to use dilutions make these a
sensible choice for any laboratory.
NAME
DESCRIPTION
PACKAGE
PART #
ANA Homogenous/dsDNA
Pattern Control
1 X 0.5mL
508181
1 X 0.5mL
508182
1 X 0.5mL
508183
1 X 0.5mL
1 X 1.0mL
508184
504089
1 X 0.5mL
508185
1 X 0.5mL
508193
1 X 0.5mL
508192
1 X 0.5mL
508195
5 X 0.5mL
708180
1 X 0.5mL
1 X 1.0mL
508101
504054
1 X 1.0mL
504090
1 X 0.5mL
508171
1 X 0.5mL
1 X 1.0mL
508191
504087
1 X 0.5mL
1 X 1.0mL
508291
504086
1 X 0.5mL
508292
Glomerular Basement
Membrane Pattern Control
1 X 0.5mL
1 X 1.0mL
508194
504085
1 X 0.5mL
508211
1 X 0.5mL
508190
Yo Purkinje Cell Positive Control* Pre-diluted human serum antibodies to Yo (Purkinje cell)
1 X 0.5mL
504009
1 X 0.5mL
504073
50
DESCRIPTION
PACKAGE
PART #
1 X 0.5mL
1 X 1.0mL
508186
508007
1 X 0.5mL
508251
1 X 0.5mL
504003
1 X 0.5mL
1 X 1.0mL
508187
504052
1 X 0.5mL
1 X 1.0mL
508154
504050
1 X 0.5mL
504005
1 X 0.5mL
508321
1 X 0.5mL
1 x 1.0mL
508331
504055
1 X 0.5mL
1 X 1.0mL
508332
504051
1 X 0.5mL
1 X 1.0mL
508188
504053
1 X 0.5mL
508351
51
IFA Conjugates
Conjugates are arguably the most critical component of the immunofluorescence assay process. The vast menu of NOVA Lite
conjugates provides a host of concentrations, specificities and contrast levels to fit individual laboratory needs.
DESCRIPTION
PACKAGE
PART #
1 X 1.0mL
504016
1 X 1.0mL
504034
1 X 1.0mL
504033
1 X 1.0mL
504014
1 X 1.0mL
504012
1 X 1.0mL
504032
1 X 1.0mL
504031
PACKAGE
PART #
DESCRIPTION
1 X 7.0mL
508126
1 X 15.0mL
504022
1 X 15.0mL
504021
FITC IgA
(Monkey Absorbed)
Conjugate no EB*
1 X 7.0mL
504015
1 X 4.0mL
1 X 7.0mL
508152
508153
52
DESCRIPTION
PACKAGE
PART #
1 X 7.0mL
1 X 15.0mL
504045
504023
Anti-Human IgG(H&L)
AFF FITC, 7ml
1 X 7.0mL
504072
1 X 7.0mL
504070
1 X 7.0mL
1 X 15.0mL
504011
504071
1 X 4.0mL
1 X 7.0mL
1 X 15.0mL
508123
508125
508113
FITC IgG Conjugate no EB Fluorescein labeled anti-human IgG conjugate no Evan's Blue
1 X 4.0mL
1 X 15.0mL
508124
508114
1 X 7.0mL
508128
1 X 7.0mL
504013
Fluorescein labeled anti-human IgG, IgA and IgM conjugate no Evan's Blue
1 X 4.0mL
1 X 15.0mL
508127
508117
1 X 15.0mL
504018
Streptavidin FITC
Conjugate*
Streptavidin FITC Conjugate (as used with the NOVA Lite Monkey Kidney Kit
704240)
1 X 3.0mL
504082
Biotin FITC Conjugate (as used with the NOVA Lite Monkey Kidney Kit
704240)
1 X 3.0mL
504083
53
NOVA Gel
OUCHTERLONY
INOVA Diagnostics produces double diffusion
test systems for the screening and semiquantitative determination of autoantibodies
to extractable nuclear antigens (ENA) in
human serum. The presence of antibodies can
be used in conjunction with other serological
tests and clinical findings to aid in the
diagnosis of connective tissue diseases.
54
DESCRIPTION
PACKAGE
PART #
A double diffusion test system for the titering and semi-quantitative determination
of autoantibodies to Jo-1 in human serum. The presence of these antibodies can aid
in the diagnosis of polymyositis and other related connective tissue diseases.
8 X 6 wells
708495
8 X 6 wells
708470
A double diffusion test system for the titering and semi-quantitative determination
of autoantibodies to Scl-70 in human serum. The presence of these antibodies aid in
the diagnosis of scleroderma.
8 X 6 wells
708475
8 X 6 wells
708410
A double diffusion test system for the titering and semi-quantitative determination
of autoantibodies to Sm/RNP in human serum. The presence of these antibodies
can aid in the diagnosis of systemic lupus erythematosus (SLE) and other related
connective tissue diseases.
8 X 6 wells
708415
8 X 6 wells
708450
A double diffusion test system for the titering and semi-quantitative determination
of autoantibodies to SS-A/SS-B in human serum. The presence of these antibodies
can aid in the diagnosis of systemic lupus erythematosus (SLE) and other related
connective tissue diseases, such as Sjgrens syndrome.
8 X 6 wells
708455
PACKAGE
PART #
Components
NAME
DESCRIPTION
8 X 6 wells
508400
8 X 6 wells
508401
1 X 0.4mL
508490
1 X 1.4mL
508491
1 X 0.7mL
508412
1 X 0.4mL
508470
1 X 1.4mL
508471
Pre-diluted Sm control
1 X 0.7mL
508411
NOVA Gel
Sm/RNP Antigen
1 X 0.4mL
508410
1 X 0.4mL
508450
1 X 0.7mL
508451
1 X 0.7mL
508452
55
Customer Support
Conditions of Sale
56
ORDERS: Orders may be placed by fax or e-mail. Please specify the catalog number and product description.
SHIPMENTS: All shipping charges will be prepaid FOB San Diego, CA and added to the invoice. Unless otherwise specified,
shipments will be made via Federal Express or UPS. Customers requesting other carriers should specify at the time of order.
TERMS: All invoices are net 30 days unless otherwise prearranged. All invoices are in U.S. dollars.
TITLE: Title to the products passes to the customer upon delivery of items ordered to the carrier.
LOSS OR DAMAGE: Claims for loss or damage of products are the responsibility of the customer and should be reported to INOVA
at the earliest possible time.
PARTIAL SHIPMENTS: INOVA will make every possible attempt to fill orders promptly and completely. When this cannot be done,
we will make partial shipments unless otherwise notified at the time of order confirmation.
RETURNS: Prior to returning any products, customers must contact INOVA technical services for approval. Please provide the
reason for the return (ordering error, shipping error, technical problem, etc.). A restocking fee may apply.
CONDITIONS: Unless otherwise indicated the products listed herein are for in vitro diagnostic use only. Nothing disclosed herein
is to be construed as a recommendation to use our products in violation of any patents. The information presented is believed
to be accurate. However, said information and products are offered without warranty or guarantee since the ultimate conditions
of use and the variability of the materials tested are beyond our control. We cannot be responsible for patent infringements or
other violations that may occur with the use of these products.